Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step…
Learn more
BIO Statement on Finalization of the Globe Model
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering…
Learn more
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on California Governor Brown Signing Drug Price Reporting & Transparency Bill
October 9, 2017
BIO will continue to oppose legislative efforts, such as SB 17, that harm patient access to needed care by undermining competition, disrupting existing drug product availability, or stifling investment in the innovation ecosystem through misguided…
BIO Congratulates SAB Biotherapeutics on Pharm Groundbreaking
October 5, 2017
Sioux Falls, S.D. 80-acre biological pharm is first-of-its kind Washington, D.C. (October 5, 2017) – Sioux Falls, S.D.-based SAB Biotherapeutics, Inc. (SAB), celebrated construction of their 80-acre biopharmaceutical production pharm operation…
Sixth Annual BIO Patient and Health Advocacy Summit Concludes Today
October 3, 2017
The 2017 Patient and Health Advocacy Summit wrapped up today, having offered the nearly 240 patient groups, companies and organizations new ways to connect, strategize, learn and partner.  For the past six years, the BIO Patient and…
BIO to Offer Complimentary Access to One-on-One Partnering™ During J.P. Morgan Healthcare Conference (“JPM Week”)
September 28, 2017
BIO will offer complimentary access to its proprietary BIO One-on-One Partnering™ during "JPM" week January 7-11, 2018 
BIO Statement on California’s Drug Price Reporting & Transparency Bill
September 13, 2017
California Senate Bill 17 is bad for patient and does not deliver on its purported promises
FDA Commissioner, Dr. Scott Gottlieb, to Address BIO Patient and Health Advocacy Summit
September 5, 2017
The head of the United States Food and Drug Administration, Dr. Scott Gottlieb, will be the keynote speaker at the BIO Patient and Health Advocacy Summit, October 2-3 at the Mayflower Hotel in Washington, DC. The annual event brings together…
PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539
September 1, 2017
Washington, DC (September 1, 2017) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) today initiated litigation in the United States District Court for the District of Nevada…
BIO Asks EPA To Use a Forward-Looking Methodology in Setting Renewable Fuel Standards
August 31, 2017
BIO today submitted comments on EPA's proposed rule on the Renewable Fuel Standard Program: Standards for 2018 and Biomass-Based Diesel Volume for 2019.
BIO Statement on Nomination of Andrei Iancu to Lead U.S. Patent and Trademark Office
August 29, 2017
Washington, D.C. (August 29, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement on the nomination of Andrei Iancu to lead the U.S. Patent and Trademark Office:“BIO congratulates Mr…
BIO Applauds Signing of Food and Drug Administration Reauthorization Act (FDARA)
August 18, 2017
Enactment of FDA User Fee package important victory for patients, medical innovation